X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15224) 15224
Newsletter (241) 241
Newspaper Article (124) 124
Magazine Article (40) 40
Book Chapter (19) 19
Dissertation (13) 13
Transcript (6) 6
Conference Proceeding (2) 2
Web Resource (2) 2
Book Review (1) 1
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11067) 11067
dexamethasone (8435) 8435
female (7495) 7495
male (7253) 7253
middle aged (4716) 4716
adult (4323) 4323
dexamethasone - administration & dosage (4055) 4055
aged (3678) 3678
dexamethasone - therapeutic use (3236) 3236
dexamethasone - adverse effects (3080) 3080
oncology (3006) 3006
animals (2874) 2874
treatment outcome (2631) 2631
hematology (2198) 2198
multiple myeloma (1835) 1835
antineoplastic combined chemotherapy protocols - therapeutic use (1735) 1735
chemotherapy (1667) 1667
therapy (1660) 1660
multiple myeloma - drug therapy (1642) 1642
steroids (1603) 1603
corticosteroids (1559) 1559
care and treatment (1526) 1526
antineoplastic combined chemotherapy protocols - adverse effects (1428) 1428
dexamethasone - pharmacology (1370) 1370
bortezomib (1338) 1338
cancer (1317) 1317
adolescent (1302) 1302
drug therapy, combination (1233) 1233
aged, 80 and over (1197) 1197
pharmacology & pharmacy (1181) 1181
research (1154) 1154
medicine & public health (1136) 1136
analysis (1130) 1130
pediatrics (1129) 1129
glucocorticoids - administration & dosage (1126) 1126
prospective studies (1115) 1115
child (1104) 1104
surgery (1103) 1103
glucocorticoids (1102) 1102
retrospective studies (1087) 1087
drug therapy (1080) 1080
rats (1072) 1072
glucocorticoids - adverse effects (1068) 1068
antineoplastic agents - adverse effects (1053) 1053
double-blind method (1010) 1010
prevention (1000) 1000
risk factors (949) 949
time factors (902) 902
double-blind (891) 891
dose-response relationship, drug (888) 888
health aspects (888) 888
pregnancy (879) 879
antiemetics - therapeutic use (856) 856
glucocorticoids - therapeutic use (856) 856
drug administration schedule (849) 849
follow-up studies (841) 841
children (834) 834
infant, newborn (834) 834
lenalidomide (825) 825
nausea (821) 821
ophthalmology (821) 821
clinical trials (820) 820
vomiting - chemically induced (820) 820
dosage and administration (816) 816
patients (784) 784
mice (769) 769
child, preschool (762) 762
efficacy (760) 760
anti-inflammatory agents - therapeutic use (753) 753
medicine, general & internal (744) 744
thalidomide (733) 733
survival (717) 717
abridged index medicus (715) 715
inflammation (715) 715
vomiting - prevention & control (713) 713
young adult (690) 690
stem-cell transplantation (675) 675
nausea - chemically induced (670) 670
antineoplastic agents - therapeutic use (649) 649
recurrence (649) 649
trial (645) 645
thalidomide - analogs & derivatives (634) 634
expression (633) 633
anti-inflammatory agents - administration & dosage (631) 631
transplantation (623) 623
infant (616) 616
combination (614) 614
thalidomide - administration & dosage (607) 607
medical research (575) 575
prognosis (575) 575
central nervous system depressants (571) 571
endocrinology & metabolism (569) 569
antineoplastic combined chemotherapy protocols - administration & dosage (565) 565
ondansetron (562) 562
management (560) 560
neurosciences (553) 553
nausea - prevention & control (551) 551
complications and side effects (549) 549
pain (549) 549
disease-free survival (528) 528
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14996) 14996
Japanese (176) 176
German (169) 169
French (109) 109
Chinese (102) 102
Spanish (70) 70
Russian (45) 45
Polish (36) 36
Portuguese (26) 26
Italian (20) 20
Czech (19) 19
Dutch (15) 15
Korean (7) 7
Hungarian (6) 6
Danish (5) 5
Persian (5) 5
Norwegian (4) 4
Turkish (4) 4
Finnish (3) 3
Swedish (3) 3
Arabic (2) 2
Croatian (2) 2
Romanian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 01/2017, Volume 12, Issue 1, pp. 176 - 189
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 11, p. CD008727
Background: Glucocorticoids play a major role in the treatment of acute lymphoblastic leukaemia (ALL). However, supraphysiological doses can suppress the... 
Pharmacology (medical) | Antineoplastic Agents, Hormonal | Dexamethasone | Fluconazole | Glucocorticoids | Childhood cancers | Pituitary‐Adrenal System | Supportive care: therapy‐related side effects during treatment | Prednisone | Randomized Controlled Trials as Topic | Supportive care: side effects of cancer treatment | Adrenal Insufficiency | Blood disorders | Precursor Cell Lymphoblastic Leukemia‐Lymphoma | Hypothalamo‐Hypophyseal System | Child health | Observational Studies as Topic | Supportive care | Acute lymphoblastic leukaemia | Medicine General & Introductory Medical Sciences | Haematological malignancies | Late effects: therapy‐related side effects after treatment | Prednisolone | Cohort Studies | Cancer | GLUCAGON STIMULATION TEST | 250 MU-G | Humans | 1ST REMISSION | Antineoplastic Agents | INSUFFICIENCY | DEATH | Glucocorticoids [administration & dosage; adverse effects] | CHILDREN | MEDICINE, GENERAL & INTERNAL | Prednisolone [administration & dosage; adverse effects] | GROWTH-HORMONE | INDUCTION THERAPY | Hypothalamo-Hypophyseal System [drug effects] | ADRENOCORTICAL RECOVERY | Precursor Cell Lymphoblastic Leukemia-Lymphoma [drug therapy] | Hormonal [administration & dosage; adverse effects] | Pituitary-Adrenal System [drug effects] | Dexamethasone [administration & dosage; adverse effects] | Child | Adrenal Insufficiency [chemically induced] | CORTISOL | Hypothalamo-Hypophyseal System - drug effects | Prednisolone - adverse effects | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisolone - administration & dosage | Prednisone - adverse effects | Pituitary-Adrenal System - drug effects | Antineoplastic Agents, Hormonal - administration & dosage | Fluconazole - administration & dosage | Dexamethasone - adverse effects | Fluconazole - adverse effects | Antineoplastic Agents, Hormonal - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Adrenal Insufficiency - chemically induced | Glucocorticoids - adverse effects
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2014, Volume 32, Issue 32, pp. 3651 - 3658
Purpose The Children's Oncology Group study AHOD0031, a randomized phase III study, was designed to evaluate the role of early chemotherapy response in... 
TRIAL | MORTALITY | ABVD | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | INVOLVED-FIELD RADIATION | PEDIATRIC-PATIENTS | DISEASE | FOLLOW-UP | CHILDHOOD-CANCER SURVIVOR | NO RADIOTHERAPY | Cyclophosphamide - administration & dosage | Hodgkin Disease - pathology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Infant | Male | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Hodgkin Disease - radiotherapy | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Female | Child | Infant, Newborn | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Bleomycin - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cisplatin - adverse effects | Vincristine - adverse effects | Doxorubicin - adverse effects | Pedi9 | ORIGINAL REPORTS | Hema14
Journal Article
Blood, ISSN 1528-0020, 2012, Volume 119, Issue 20, pp. 4619 - 4624
Approximately 5-10% of diffuse large B-cell lymphomas (DLBCL) harbor a 8q24/MYC rearrangement (MYC+). We determined the prognostic significance of MYC... 
REARRANGEMENT | IMPACT | POOR-PROGNOSIS | T(14/18) | IN-SITU HYBRIDIZATION | CLASSIFICATION | HEMATOLOGY | EXPRESSION | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Podophyllotoxin - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cisplatin - administration & dosage | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Melphalan - adverse effects | Immunotherapy | Treatment Failure | Podophyllotoxin - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Carmustine - adverse effects | Genes, myc - physiology | Dexamethasone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Ifosfamide - adverse effects | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Melphalan - administration & dosage | Ifosfamide - administration & dosage | Cisplatin - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Carmustine - administration & dosage | Life Sciences | Biochemistry, Molecular Biology | Lymphoma, Large B-Cell, Diffuse | Podophyllotoxin | methods | Genes, myc | Cytarabine | genetics | administration & dosage | Melphalan | Antibodies, Monoclonal, Murine-Derived | Dexamethasone | drug therapy | Ifosfamide | Carmustine | therapy | Antineoplastic Combined Chemotherapy Protocols | Etoposide | physiology | Hematopoietic Stem Cell Transplantation | Cisplatin | adverse effects | mortality
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2012, Volume 104, Issue 18, pp. 1386 - 1395
.... Univariate logistic regression was used to estimate the effect of intensity of chemotherapy (treatment arm... 
ATTENTION | LONG-TERM SURVIVORS | NEUROPSYCHOLOGICAL PERFORMANCE | ONCOLOGY | FRONTAL-CORTEX | DEVELOPMENTAL MODEL | SEX-DIFFERENCES | RADIATION | WHITE-MATTER VOLUME | WORKING-MEMORY | CHILDREN | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Precursor Cell Lymphoblastic Leukemia-Lymphoma - psychology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Infant | Male | Cytarabine - adverse effects | Patient Selection | Hydrocortisone - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Attention - drug effects | Vincristine - administration & dosage | Female | Child | Injections, Spinal | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Risk Factors | Mercaptopurine - administration & dosage | Mercaptopurine - adverse effects | Logistic Models | Treatment Outcome | Cognition - drug effects | Cranial Irradiation - adverse effects | Remission Induction | Cytarabine - administration & dosage | Intelligence Tests | Methotrexate - adverse effects | Hydrocortisone - adverse effects | Adolescent | Sex Factors | Vincristine - adverse effects | Methotrexate - administration & dosage | Intelligence - drug effects | Care and treatment | Patient outcomes | Acute lymphocytic leukemia | Research | Cognition disorders | Risk factors | Cancer in children
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 11/2012, Volume 122, Issue 11, pp. 4172 - 4189
Journal Article
European spine journal, ISSN 1432-0932, 2013, Volume 22, Issue 9, pp. 2089 - 2096
Major spine surgery with multilevel instrumentation is followed by large amount of opioid consumption, significant pain and difficult mobilization in a... 
Mobilization | Surgical Orthopedics | Medicine & Public Health | Opioid consumption | Multimodal pain treatment | Major spine surgery | Neurosurgery | MORPHINE | FUSION SURGERY | METHYLPREDNISOLONE | TRENDS | CLINICAL NEUROLOGY | ISSUES | RECOVERY | TOTAL DISC REPLACEMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PLACEBO-CONTROLLED TRIAL | ORTHOPEDICS | Acetaminophen - adverse effects | Postoperative Nausea and Vomiting - chemically induced | Pain, Postoperative - drug therapy | Humans | Middle Aged | Acetaminophen - administration & dosage | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | gamma-Aminobutyric Acid - administration & dosage | Spinal Fusion - adverse effects | Case-Control Studies | Young Adult | Analgesics, Opioid - adverse effects | Analgesics, Non-Narcotic - adverse effects | Aged, 80 and over | Amines - administration & dosage | Adult | Antiemetics - adverse effects | Female | Amines - adverse effects | Drug Therapy, Combination | gamma-Aminobutyric Acid - adverse effects | Spinal Diseases - surgery | Dexamethasone - administration & dosage | Cyclohexanecarboxylic Acids - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Analgesics, Non-Narcotic - administration & dosage | Postoperative Nausea and Vomiting - drug therapy | Analgesics, Opioid - administration & dosage | Adolescent | Aged | Care and treatment | Pain | Corticosteroids | Anesthesia | Morphine | Nausea | Chronic pain | Original
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2018, Volume 2019, Issue 3, p. CD011940
Journal Article